Subscribe to RSS
DOI: 10.1055/s-0029-1218530
Efficient Copper-Catalyzed Synthesis of 4-Aminoquinazoline and 2,4-Diaminoquinazoline Derivatives
Publication History
Publication Date:
01 December 2009 (online)

Abstract
We have developed an efficient copper-catalyzed method for the synthesis of 4-aminoquinazoline and 2,4-diaminoquinazoline derivatives via reactions of substituted 2-bromo-benzonitriles with amidines or guanidine, and the method is of economical and practical advantage.
Key words
copper - Ullmann-type reaction - cross-coupling - quinazoline - synthetic method
- Supporting Information for this article is available online:
- Supporting Information
- 1
Ple PA.Green TP.Hennequin LF.Curwen J.Fennell M.Allen J.Lambertvan der Brempt C.Costello G. J. Med. Chem. 2004, 47: 871 - 2a
Colotta V.Catarzi D.Varano F.Lenzi O.Filacchioni G.Costagli C.Galli A.Ghelardini C.Galeotti N.Gratteri P.Sgrignani J.Deflorian F.Moro S. J. Med. Chem. 2006, 49: 6015 - 2b
Lewerenz A.Hentschel S.Vissiennon Z.Michael S.Nieber K. Drug Dev. Res. 2003, 58: 420 - 3
Malecki N.Carato P.Rigo G.Goossens JF.Houssin R.Bailly C.Henichart JP. Bioorg. Med. Chem. 2004, 12: 641 - 4a
Doyle LA.Ross DD. Oncogene 2003, 22: 7340 - 4b
Henderson EA.Bavetsias V.Theti DS.Wilson SC.Clauss R.Jackman AL. Bioorg. Med. Chem. 2006, 14: 5020 - 5a
Chien T.-C.Chen C.-S.Yu F.-H.Chern J.-W. Chem. Pharm. Bull. 2004, 52: 1422 - 5b
Herget T.Freitag M.Morbitzer M.Kupfer R.Stamminger T.Marschall M. Antimicrob. Agents Chemother. 2004, 48: 4154 - 6a
Waisser K.Gregor J.Dostal H.Kunes J.Kubicova L.Klimesova V.Kaustova J. Farmaco 2001, 56: 803 - 6b
Kunes J.Bazant J.Pour M.Waisser K.Slosarek M.Janota J. Farmaco 2000, 55: 725 - 7a
Nakagami K,Yokoi S,Nishimura K,Nagai S,Honda T,Oda K,Fujii K,Kobayashi R, andKojima M. inventors; US 4323680. - 7b
Haley GJ. inventors; US 5373011. - 8a
Palanki MSS, andSuto MJ. inventors; US 5939421. - 8b
Myers MR,Spada AP,Maguire MP,Persons PE,Zilberstein A,Hsu C.-Y.-J, andJohnson SE. inventors; US 5714493. - 9a
Barker AJ. inventors; US 5942514. - 9b
Barker AJ. inventors; US 5932574. - 10a
Nauta WT. inventors; US 3980650. - 10b
Mizogami S,Hiranuma H,Sekiya T, andHanazuka M. inventors; US 4607034. - 11a
Elslager EF.Davoll J. In Lectures in Heterocyclic Chemistry 2Castle RN.Townsend LB. Hetero Corp.; Orem Utah (USA): 1974. - 11b
Elslager EF.Johnson JL.Werbel LM. J. Med. Chem. 1983, 26: 1753 - 12
Grivsky EM.Lee S.Sigel CW.Duch DS.Nichol CA. J. Med. Chem. 1980, 23: 327 - 13a
Bertino JR.Sawacki WL.Moroson BA.Cashmore AR.Elslager EF. Biochem. Pharmacol. 1979, 28: 1983 - 13b
Weir EC.Cashmore AR.Dreyer RN.Graham ML.Hsiao N.Moroson BA.Sawacki WL.Bertino JR. Cancer Res. 1982, 42: 1696 - 13c
Duch DS.Edelstein MP.Bowers SW.Nichol CA. Cancer Res. 1982, 42: 3987 - 13d
Lin JT.Cashmore AR.Baker M.Dreyer RN.Ernstoff M.Marsh JC.Bertino JR.Whitfield LR.Delap R.Grillo-Lopez A. Cancer Res. 1987, 47: 609 - 13e
Kovacs JA.Allegra CA.Swan JC.Drake JC.Parillo JE.Chabner BA.Masur H. Antimicrob. Agents Chemother. 1988, 32: 430 - 14 Am. J. Hosp. Pharm. 1994, 51: 591
- 15a
Graffner-Nordberg M.Fyfe M.Brattsand R.Mellgård B.Hallberg A. J. Med. Chem. 2003, 46: 3455 - 15b
Graffner-Nordberg M.Marelius J.Ohlsson S.Persson A.Swedberg G.Andersson P.Andersson SE.Åqvist J.Hallberg A. J. Med. Chem. 2000, 43: 3852 - 15c
Graffner-Nordberg M.Kolmodin K.Åqvist J.Queener SF.Hallberg A. J. Med. Chem. 2001, 44: 2391 - 16
Thurmond J.Butchbach MER.Palomo M.Pease B.Rao M.Bedell L.Keyvan M.Pai G.Mishra R.Haraldsson M.Andresson T.Bragason G.Thosteinsdottir M.Bjornsson JM.Coovert DD.Burghes AHM.Gurney ME.Singh J. J. Med. Chem. 2008, 51: 449 - 17a
Chowdhury SF.Villamor VB.Guerrero RH.Leal I.Brun R.Croft SL.Goodman JM.Maes L.Ruiz-Pérez LM.Pacanowska DG.Gilbert IH. J. Med. Chem. 1999, 42: 4300 - 17b
Chowdhury SF.Guerrero RH.Brun R.Ruiz-Pérez LM.Pacanowska DG.Gilbert IH. J. Enzym. Inhib. Med. Chem. 2002, 17: 293 - 17c
Pez D.Leal I.Zuccotto F.Boussard C.Brun R.Croft SL.Yardley V.Ruiz-Pérez LM.Gonzalez-Pacanowska D.Gilbert IH. Bioorg. Med. Chem. 2003, 11: 4693 - 18
Vaidya CM.Wright JE.Rosowsky A. J. Med. Chem. 2002, 45: 1690 - 19
Stevens MFG. J. Chem. Soc. C 1967, 1096 - 20
Sutherland DR.Tennant G. J. Chem. Soc., Perkin Trans. 1 1974, 534 - 21
Seijas JA.Vázquez-Tato MP.Martínez MM. Tetrahedron Lett. 2000, 41: 2215 - 22
Rad-Moghadam K.Samavi L. J. Heterocycl. Chem. 2006, 43: 913 - 23
Rosowsky A.Chen H. J. Org. Chem. 2001, 66: 7522 - For recent reviews on copper-catalyzed N-arylation, see:
- 24a
Kunz K.Scholz U.Ganzer D. Synlett 2003, 2428 - 24b
Ley SV.Thomas AW. Angew. Chem. Int. Ed. 2003, 42: 5400 - 24c
Beletskaya IP.Cheprakov AV. Coord. Chem. Rev. 2004, 248: 2337 - 24d
Evano G.Blanchard N.Toumi M. Chem. Rev. 2008, 108: 3054 ; and references cited therein - For recent studies on the synthesis of N-heterocycles through Ullmann-type couplings, see:
- 25a
Martin R.Rodríguez R.Buchwald SL. Angew. Chem. Int. Ed. 2006, 45: 7079 - 25b
Evindar G.Batey RA. J. Org. Chem. 2006, 71: 1802 - 25c
Bonnaterre F.Bois-Choussy M.Zhu J. Org. Lett. 2006, 8: 4351 - 25d
Zou B.Yuan Q.Ma D. Angew. Chem. Int. Ed. 2007, 46: 2598 - 25e
Yuan X.Xu X.Zhou X.Yuan J.Mai L.Li Y. J. Org. Chem. 2007, 72: 1510 - 26a
Liu X.Fu H.Jiang Y.Zhao Y. Angew. Chem. Int. Ed. 2009, 48: 348 - 26b
Huang C.Fu Y.Fu H.Jiang Y.Zhao Y. Chem. Commun. 2008, 6333 - 26c
Yang D.Fu H.Hu L.Jiang Y.Zhao Y. J. Org. Chem. 2008, 73: 7841
References and Notes
General Procedure
for the Synthesis of Compounds 3a-m
A
25 mL round-bottom flask was charged with a magnetic stirrer
and DMF (3 mL), substituted 2-bromobenzonitrile (1, 1
mmol), amidine hydrochloride (2, 1.2 mmol),
DMEDA (0.2 mmol, 18 mg), and K2CO3 (2 mmol,
138 mg) [2 mmol (656 mg) of Cs2CO3 were
used for acetamidine hydro-chloride] after stirring of
the mixture for 15 min under nitrogen atmosphere, and CuI (0.1 mmol,
19 mg) was added to the flask. The mixture was stirred at 80 ˚C
for the time indicated in Table
[²]
.
The resulting mixture was cooled to r.t. and filtered. The solid
was washed with DMF (2 × 3 mL), and the
combined filtrate was concentrated by the rotary evaporator, and
the residue was purified by column chromatography on silica gel
using CHCl3-MeOH (40:1 to 5:1) as eluent to
give the desired product.
Cyclopropyl-4-aminoquinazoline
(3c)
Eluent CHCl3-MeOH (40:1).
Yield 134 mg (72%). White solid; mp 198-200 ˚C. ¹H
NMR (300 MHz, DMSO-d
6): δ = 8.12
(d, 1 H, J = 7.9
Hz), 7.58 (m, 4 H), 7.34 (t, 1 H, J = 7.4 Hz),
1.99 (m, 1 H, J = 7.5
Hz), 1.05-0.87 (m, 4 H). ¹³C
NMR (75 MHz, DMSO-d
6): δ = 167.6,
162.3, 150.5, 133.2, 126.9, 124.5, 124.0, 113.4, 18.4, 9.4. HRMS: m/z calcd for C11H11N3 [M + H]+:
186.1031; found: 186.1037.